Literature DB >> 12884066

Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users.

M Miller1, C Cespedes, P Vavagiakis, R S Klein, F D Lowy.   

Abstract

HIV-infected individuals, especially those with a history of injecting drug use, are at high risk of Staphylococcus aureus infection. Moreover, the use of antimicrobial agents for opportunistic infections may increase nasal colonization by antimicrobial-resistant Staphylococcus aureus in this population and, subsequently, levels of infection with multidrug-resistant Staphylococcus aureus in the community. Between February 1999 and March 2000, 500 subjects from a community-based cohort of drug users completed an interview and underwent a physical exam. Risk factors for colonization by Staphylococcus aureus were examined, the antibiotic susceptibility profiles of all strains were determined, and DNA strain analysis was performed. One hundred twenty (24%) subjects had positive Staphylococcus aureus nasal cultures. Only HIV infection and homelessness were associated with Staphylococcus aureus colonization. Ten (8%) isolates were methicillin-resistant Staphylococcus aureus. Methicillin-resistant Staphylococcus aureus isolates were found more frequently among HIV-infected than HIV-uninfected respondents (14% vs. 3%, P=0.04). Among those colonized and HIV infected, the mean number of resistant isolates was higher for those currently reporting antibiotic use (5.0 vs. 2.3, P<0.001) and for those with CD4+ counts <or =200/ microl (3.8 vs. 2.3, P=0.02). The increased use of antimicrobial agents in HIV-infected individuals colonized with Staphylococcus aureus may be an underlying mechanism that contributes to the presence of multidrug-resistant Staphylococcus aureus in the community.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884066     DOI: 10.1007/s10096-003-0969-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Bacterial infections and skin cleaning prior to injection among intravenous drug users.

Authors:  D Vlahov; M Sullivan; J Astemborski; K E Nelson
Journal:  Public Health Rep       Date:  1992 Sep-Oct       Impact factor: 2.792

2.  Assessment of resolution and intercenter reproducibility of results of genotyping Staphylococcus aureus by pulsed-field gel electrophoresis of SmaI macrorestriction fragments: a multicenter study.

Authors:  A van Belkum; W van Leeuwen; M E Kaufmann; B Cookson; F Forey; J Etienne; R Goering; F Tenover; C Steward; F O'Brien; W Grubb; P Tassios; N Legakis; A Morvan; N El Solh; R de Ryck; M Struelens; S Salmenlinna; J Vuopio-Varkila; M Kooistra; A Talens; W Witte; H Verbrugh
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

3.  Nosocomial bloodstream infections among human immunodeficiency virus-infected patients: incidence and risk factors.

Authors:  Nicola Petrosillo; Pierluigi Viale; Emanuele Nicastri; Claudio Arici; Enrico Bombana; Alberto Casella; Francesco Cristini; Michele De Gennaro; Ferdinando Dodi; Andrea Gabbuti; Gianni Gattuso; Laura Irato; Paolo Maggi; Federico Pallavicini; Angelo Pan; Mario Pantaleoni; Giuseppe Ippolito
Journal:  Clin Infect Dis       Date:  2002-01-25       Impact factor: 9.079

4.  Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

Authors:  J N Martin; D A Rose; W K Hadley; F Perdreau-Remington; P K Lam; J L Gerberding
Journal:  J Infect Dis       Date:  1999-12       Impact factor: 5.226

5.  Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

Authors:  T S Naimi; K H LeDell; D J Boxrud; A V Groom; C D Steward; S K Johnson; J M Besser; C O'Boyle; R N Danila; J E Cheek; M T Osterholm; K A Moore; K E Smith
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

6.  Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome.

Authors:  A Senthilkumar; S Kumar; J N Sheagren
Journal:  Clin Infect Dis       Date:  2001-09-17       Impact factor: 9.079

7.  Smallpox Vaccine Adverse Events Monitoring and Response System for the first stage of the smallpox vaccination program.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-02-07       Impact factor: 17.586

8.  Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients.

Authors:  M H Nguyen; C A Kauffman; R P Goodman; C Squier; R D Arbeit; N Singh; M M Wagener; V L Yu
Journal:  Ann Intern Med       Date:  1999-02-02       Impact factor: 25.391

9.  Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users.

Authors:  I J Spijkerman; E J van Ameijden; G H Mientjes; R A Coutinho; A van den Hoek
Journal:  J Clin Epidemiol       Date:  1996-10       Impact factor: 6.437

10.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

View more
  13 in total

Review 1.  Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection.

Authors:  Kathy Thompson; Francesca Torriani
Journal:  Curr HIV/AIDS Rep       Date:  2006-09       Impact factor: 5.071

2.  The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals.

Authors:  Rachel J Gordon; Nancy Chez; Haomiao Jia; Barbara Zeller; Magda Sobieszczyk; Caitlin Brennan; Katherine B Hisert; Mei-Ho Lee; Peter Vavagiakis; Franklin D Lowy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

3.  Staphylococcus aureus colonization and infection among drug users: identification of hidden networks.

Authors:  Robert A Gwizdala; Maureen Miller; Meera Bhat; Peter Vavagiakis; Christopher Henry; Alan Neaigus; Qiuhu Shi; Franklin D Lowy
Journal:  Am J Public Health       Date:  2011-07       Impact factor: 9.308

Review 4.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Patterns and determinants of inappropriate antibiotic use in injection drug users.

Authors:  Joanna L Starrels; Frances K Barg; Joshua P Metlay
Journal:  J Gen Intern Med       Date:  2008-12-12       Impact factor: 5.128

6.  The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era.

Authors:  M D Burkey; L E Wilson; R D Moore; G M Lucas; J Francis; K A Gebo
Journal:  HIV Med       Date:  2008-08-21       Impact factor: 3.180

7.  Prevalence and behavioural risk factors of Staphylococcus aureus nasal colonization in community-based injection drug users.

Authors:  N S Leung; P Padgett; D A Robinson; E L Brown
Journal:  Epidemiol Infect       Date:  2014-12-01       Impact factor: 4.434

8.  Methicillin-resistant Staphylococcus aureus in HIV-infected patients.

Authors:  Alicia I Hidron; Russell Kempker; Abeer Moanna; David Rimland
Journal:  Infect Drug Resist       Date:  2010-08-06       Impact factor: 4.003

9.  High Prevalence of Malnutrition among the Above Thirteen with Primary Pyomyositis in Northern Uganda.

Authors:  David Lagoro Kitara; Paul Okot Bwangamoi; Henry Wabinga; Michael Odida
Journal:  Br J Med Med Res       Date:  2015

10.  Isolation of Methicillin-Resistant Staphylococcus aureus (MRSA) from HIV Patients Referring to HIV Referral Center, Shiraz, Iran, 2011-2012.

Authors:  Parvin Hassanzadeh; Yashgin Hassanzadeh; Jalal Mardaneh; Esmaeel Rezai; Mohammad Motamedifar
Journal:  Iran J Med Sci       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.